Indegene Limited
American Funds (Capital Group) trimmed its stake in Indegene Limited from 1.75% to 1.42%, selling 813,672 shares. The value of the sold shares was ₹44.38 crore, at a price of ₹545.25 per share.
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
India equity holdings of American Funds, the mutual fund family of Capital Group. Long-only, fundamentally driven strategy.